Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia

AIM: Parkinson’s disease and schizophrenia are clinical end points of dopaminergic deficit and excess, respectively, in the mid-brain. In accordance, current pharmacological interventions aim to restore normal dopamine levels, the overshooting of which culminates in adverse effects which results in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ashish Kumar, Pokhriyal, Ruchika, Khan, Mohd Imran, Kumar, Domada Ratna, Gupta, Rishab, Chadda, Rakesh Kumar, Ramachandran, Rashmi, Goyal, Vinay, Tripathi, Manjari, Hariprasad, Gururao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781638/
https://www.ncbi.nlm.nih.gov/pubmed/31632033
http://dx.doi.org/10.2147/NDT.S214217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781638/
https://www.ncbi.nlm.nih.gov/pubmed/31632033
http://dx.doi.org/10.2147/NDT.S214217

Ejemplares similares